Dodecylglycerol provides partial protection against glutamate toxicity in neuronal cultures derived from different regions of embryonic rat brain

被引:11
作者
Dave, JR
Koenig, ML
Tortella, FC
Pieringer, RA
Doctor, BP
Ved, HS
机构
[1] WALTER REED ARMY MED CTR, WALTER REED ARMY INST RES, DIV BIOCHEM, WASHINGTON, DC 20307 USA
[2] TEMPLE UNIV, SCH MED, DEPT BIOCHEM, PHILADELPHIA, PA 19122 USA
关键词
dodecylglycerol; primary neuronal cultures; glycerol alkyl lipid; calcium mobilization; glutamate toxicity; neurotoxicity;
D O I
10.1007/BF02815146
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Primary cultures enriched in neurons dissociated from embryonic rat cerebral cortex, cerebellum, or hippocampus were treated in a chemically defined serum-free media with either vehicle, dodecylglycerol (DDG, 3 mu M), or glutamate (75 mu M), or preincubated with DDG for 4 or 24 h, and further incubated with glutamate. Their morphological and biochemical assessments (lactate dehydrogenase [LDH] release in the culture media, neuronal viability and intracellular Ca2+ mobilization) were made. Neurotoxic effects of glutamate and glutamate-mediated increases in intracellular Ca2+ were maximal in neurons from cerebellum and minimal in neurons from cortex. Cotreatment of cells with DDG and glutamate failed to provide significant neuronal protection against glutamate in the three brain regions. Pretreatment of cells with DDG for 4 or 24 h prior to glutamate treatment provided significant neuroprotection as judged by morphological changes and a decrease in LDH activity. Neuroprotection of approximately 15-35% was observed following 4 h of DDG pretreatment, increasing to 60-85% protection after 24 h of DDG pretreatment. Although the mechanism of DDG's neuroprotective action remains to be elucidated, these results demonstrate that both glutamate and DDG have differential specificity for anatomical regions of the brain.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 35 条
[1]   HUMAN PROTOONCOGENE C-JUN ENCODES A DNA-BINDING PROTEIN WITH STRUCTURAL AND FUNCTIONAL-PROPERTIES OF TRANSCRIPTION FACTOR AP-1 [J].
BOHMANN, D ;
BOS, TJ ;
ADMON, A ;
NISHIMURA, T ;
VOGT, PK ;
TJIAN, R .
SCIENCE, 1987, 238 (4832) :1386-1392
[2]  
BRAQUET P, 1987, PHARMACOL REV, V39, P97
[3]   CASCADE INDUCTION OF C-FOS, C-MYC, AND HEAT-SHOCK 70K TRANSCRIPTS DURING REGRESSION OF THE RAT VENTRAL PROSTATE-GLAND [J].
BUTTYAN, R ;
ZAKERI, Z ;
LOCKSHIN, R ;
WOLGEMUTH, D .
MOLECULAR ENDOCRINOLOGY, 1988, 2 (07) :650-657
[4]  
CHOI DW, 1987, J PHARMACOL EXP THER, V242, P713
[5]  
CHOI DW, 1987, J NEUROSCI, V7, P369
[6]  
COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143
[7]   ANATOMICAL ORGANIZATION OF EXCITATORY AMINO-ACID RECEPTORS AND THEIR PATHWAYS [J].
COTMAN, CW ;
MONAGHAN, DT ;
OTTERSEN, OP ;
STORMMATHISEN, J .
TRENDS IN NEUROSCIENCES, 1987, 10 (07) :273-280
[8]  
Dave J. R., 1993, Society for Neuroscience Abstracts, V19, P1771
[9]   REGIONAL CHANGES IN C-FOS MESSENGER-RNA IN RAT-BRAIN AFTER IV-NMDA OR ICV-NMDA NMDA INJECTIONS [J].
DAVE, JR ;
TORTELLA, FC .
NEUROREPORT, 1994, 5 (13) :1645-1648
[10]   THE NEUROPROTECTIVE KAPPA-OPIOID CI-977 ALTERS GLUTAMATE-INDUCED CALCIUM SIGNALING IN-VITRO [J].
DECOSTER, MA ;
CONOVER, JR ;
HUNTER, JC ;
TORTELLA, FC .
NEUROREPORT, 1994, 5 (17) :2305-2310